These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Neuroprotection for treatment of glaucoma in adults. Sena DF; Lindsley K Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006539. PubMed ID: 28122126 [TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Retinal Ganglion Cell Distress in Glaucoma and Neuroprotective Potential Intervention. Vernazza S; Oddone F; Tirendi S; Bassi AM Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360760 [TBL] [Abstract][Full Text] [Related]
9. DRP1 inhibition rescues retinal ganglion cells and their axons by preserving mitochondrial integrity in a mouse model of glaucoma. Kim KY; Perkins GA; Shim MS; Bushong E; Alcasid N; Ju S; Ellisman MH; Weinreb RN; Ju WK Cell Death Dis; 2015 Aug; 6(8):e1839. PubMed ID: 26247724 [TBL] [Abstract][Full Text] [Related]
10. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. Harada T; Harada C; Nakamura K; Quah HM; Okumura A; Namekata K; Saeki T; Aihara M; Yoshida H; Mitani A; Tanaka K J Clin Invest; 2007 Jul; 117(7):1763-70. PubMed ID: 17607354 [TBL] [Abstract][Full Text] [Related]
11. A Dietary Combination of Forskolin with Homotaurine, Spearmint and B Vitamins Protects Injured Retinal Ganglion Cells in a Rodent Model of Hypertensive Glaucoma. Cammalleri M; Dal Monte M; Amato R; Bagnoli P; Rusciano D Nutrients; 2020 Apr; 12(4):. PubMed ID: 32340314 [TBL] [Abstract][Full Text] [Related]
12. Current perspective of neuroprotection and glaucoma. Tian K; Shibata-Germanos S; Pahlitzsch M; Cordeiro MF Clin Ophthalmol; 2015; 9():2109-18. PubMed ID: 26635467 [TBL] [Abstract][Full Text] [Related]
13. Adaptive Immunity: New Aspects of Pathogenesis Underlying Neurodegeneration in Glaucoma and Optic Neuropathy. Jiang S; Kametani M; Chen DF Front Immunol; 2020; 11():65. PubMed ID: 32117239 [TBL] [Abstract][Full Text] [Related]
15. Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension. Clement Freiberg J; von Spreckelsen A; Kolko M; Azuara-Blanco A; Virgili G Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013817. PubMed ID: 35686679 [TBL] [Abstract][Full Text] [Related]
16. A review of potential novel glaucoma therapeutic options independent of intraocular pressure. Shalaby WS; Ahmed OM; Waisbourd M; Katz LJ Surv Ophthalmol; 2022; 67(4):1062-1080. PubMed ID: 34890600 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective therapies for glaucoma. Song W; Huang P; Zhang C Drug Des Devel Ther; 2015; 9():1469-79. PubMed ID: 25792807 [TBL] [Abstract][Full Text] [Related]
18. Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma. Chiasseu M; Cueva Vargas JL; Destroismaisons L; Vande Velde C; Leclerc N; Di Polo A J Neurosci; 2016 May; 36(21):5785-98. PubMed ID: 27225768 [TBL] [Abstract][Full Text] [Related]
19. Aldosterone: a mediator of retinal ganglion cell death and the potential role in the pathogenesis in normal-tension glaucoma. Nitta E; Hirooka K; Tenkumo K; Fujita T; Nishiyama A; Nakamura T; Itano T; Shiraga F Cell Death Dis; 2013 Jul; 4(7):e711. PubMed ID: 23828574 [TBL] [Abstract][Full Text] [Related]
20. Effect of dietary modification and antioxidant supplementation on intraocular pressure and open-angle glaucoma. Jabbehdari S; Chen JL; Vajaranant TS Eur J Ophthalmol; 2021 Jul; 31(4):1588-1605. PubMed ID: 33008269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]